Amgen Doubles Down On AI, Genomic Investments In R&D

New Tech, R&D Heads ‘Joined At The Hip’

Concept of artificial intelligence. Digital, communication, science, networks
Amgen is using artificial intelligence to search genomic data for new drug targets, among other uses • Source: Shutterstock

More from AI

More from Digital Technologies